|
1
|
Li JJ, Li JJ, Li J, Trehan AK, Wong HS, Krishnananthan S, Kennedy LJ, Gao Q, Ng A, Robl JA, Balasubramanian B, Chen BC. A Synthesis of N-Bridged 5,6-Bicylic Pyridines via A Mild Cyclodehydration Using the Burgess Reagent and Discovery of A Novel Carbamylsulfonylation Reaction. Org Lett 2008; 10:2897-900. [DOI: 10.1021/ol8011748] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Jie Jack Li
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - James J. Li
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Jun Li
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Ashok K. Trehan
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Henry S. Wong
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Subramanian Krishnananthan
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Lawrence J. Kennedy
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Qi Gao
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Alicia Ng
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Jeffrey A. Robl
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Balu Balasubramanian
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| | - Bang-Chi Chen
- Discovery Chemistry, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492, Discovery Chemistry, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, and Discovery Chemistry, Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, New Jersey 08543
| |
Collapse
|
|
2
|
Adachi H, Tanaka H. Effects of a new cardiotonic phosphodiesterase III inhibitor, olprinone, on cardiohemodynamics and plasma hormones in conscious pigs with heart failure. J Cardiovasc Pharmacol 1997; 29:763-71. [PMID: 9234657 DOI: 10.1097/00005344-199706000-00009] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
We examined the effects of a novel phosphodiesterase III inhibitor, olprinone, on the cardiohemodynamics and plasma hormones in conscious pigs with pacing-induced heart failure. After pacing for 5-10 days, cardiac output (CO) decreased from 2.25 +/- 0.17 to 1.67 +/- 0.13 L/min (n = 8, p < 0.01) and stroke volume (SV) decreased from 20.1 +/- 2.1 to 12.0 +/- 1.6 ml (n = 8, p < 0.01), whereas left arterial pressure (LAP) increased from 2.8 +/- 1.2 to 16.7 -/+ 0.9 mm Hg (n = 7, p < 0.001) and systemic vascular resistance (SVR) increased from 38.7 +/- 3.5 to 49.8 +/- 4.2 mm Hg/L/min (n = 8, p < 0.01). Sequential intravenous infusions of 0.03, 0.3, and 3.0 microg/kg/min of olprinone at 30-min intervals to eight pigs caused dose-dependent increases in the decreased CO, SV, and maximal rate of rise in left ventricular pressure (LV dP/dt(max)) and decreased the elevated LAP and SVR. Olprinone at 3.0 microg/kg/min maximally increased CO, SV, and LV dP/dt(max) by 40.0 +/- 10.8% (p < 0.05 vs. vehicle), 25.6 +/- 6.9% (p < 0.05), and 43.9 +/- 11.2% (p < 0.01), respectively, and brought about a slight increase in heart rate and decreases in LAP and SVR, by 35.9 +/- 7.3% (p < 0.001) and 27.9 +/- 4.8% (p < 0.01), respectively. Olprinone did not affect the rate-pressure product. In addition, olprinone produced significant decreases in the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate, with no changes in the plasma levels of cyclic adenosine monophosphate and catecholamines or plasma renin activity. These findings indicate that the short-term intravenous infusions of olprinone ameliorated the decreased left ventricular function without affecting myocardial oxygen consumption or the sympathetic nervous system in conscious pigs with heart failure.
Collapse
Affiliation(s)
- H Adachi
- Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan
| | | |
Collapse
|